Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,283.9
3.9 (0.12%)

 

  • STI Straits Times Index
    3,283.9
    3.9 (0.12%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,530.3
    -12.6 (-0.82%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,127.8
    15.1 (0.06%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,558.2
    -11.7 (-0.33%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,043.2M
  • Value: 1,204.6M
  • Rise: 113
  • Fall: 196
  • Unch: 451

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.003-
DISA0.008-0.001
Sembcorp Marine0.083+0.001
Jiutian Chemical0.083+0.001
RH PetroGas0.189-0.002
Beverly JCG0.002-
ThaiBev0.640-
HGH0.012+0.001
Oceanus0.029-
Genting Sing0.780-

World Indices

World Indices
Name Last Change
Nasdaq 14,506.9 -386.9
HSI 24,127.8 +15.1
HSCEI 8,441.7 -7.3
Jakarta 6,592.0 -22.1
Nikkei 225 27,467.2 -790.0
SSE Comp 3,558.2 -11.7
Shanghai A 3,728.8 -12.3
Shanghai B 287.0
KOSPI 2,842.3 -22.0

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

VIVEVE MEDICAL INC VIVEVE MEDICAL
Updated on 18 Jan 2022 (End of trading day)
Last (USD): 1.110 Change: -0.030 High: 1.130 Remarks: -
Change (%): -2.63 Low: 1.100
Open 1.110 Yesterday's Close 1.1400000000000001
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 33,363 Cumulative Value

Company Background

Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. It offers cryogen-cooled monopolar radio frequency technology, which delivered through a radiofrequency generator, hand piece and treatment tip. The Viveve system is a non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company was founded on March 3, 1987 and is headquartered Englewood, CO.

Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.45826 Trailing EPS (USD) b -2.35480 NAV (USD) c 1.9208
PE a - Trailing PE d - Price / NAV c 0.5779
Dividend Yield (%) e - Cash In Hand (USD) f 2.1377 Issued & Paid-up Shares g 10,602,600
Piotroski F Score 1 Market Cap (M) 11.769 Free Float (%) 95.8
Return on Equity (ROE) (%) h n.m. Revenue Growth (%) TTM i 33.795
Net Earnings Growth (%) j 29.512 Net Debt/Equity k Net Cash
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 15 Nov 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.060
-5.13 %
10 Days --0.150
-11.90 %
20 Days --0.250
-18.38 %
Medium Term Return 3 Months --1.170
-51.32 %
6 Months --1.510
-57.63 %
1 Year --2.140
-65.85 %
Long Term Return 2 Years --10.690
-90.59 %
3 Years --1118.890
-99.90 %
5 Years --5268.890
-99.98 %
Annualised Return Annualised --
-81.60 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference VIVEVE MEDICAL INC NASDAQ 11.769 - - 0.5779 -
Industry Medical Specialties NASDAQ 2,644.273 151.230 195.223 9.0105 0.030
Local Peer INTUITIVE SURGICAL INC NASDAQ 105,481.656 - - - -
Local Peer IDEXX LABORATORIES INC NASDAQ 43,937.500 75.523 58.052 58.2142 -
Local Peer DEXCOM INC NASDAQ 41,663.860 84.408 78.715 19.5046 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 38,603.324 21.737 52.163 10.9770 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 22,640.023 31.116 49.085 6.8246 -
Local Peer HOLOGIC INC NASDAQ 17,451.132 9.325 9.325 4.1367 -
Local Peer INSULET CORPORATION NASDAQ 16,145.245 2,374.239 - 32.4265 -
Local Peer ABIOMED INC NASDAQ 13,302.559 58.985 89.188 9.6078 -
Local Peer MASIMO CORPORATION NASDAQ 12,350.333 51.395 53.221 8.4122 -
Local Peer DENTSPLY SIRONA INC NASDAQ 11,621.148 - 27.835 2.2689 0.753
Local Peer BRUKER CORPORATION NASDAQ 10,365.619 65.688 38.349 9.6371 0.235
Local Peer TANDEM DIABETES CARE INC NASDAQ 7,384.406 - 339.388 18.9513 -
Other Local Peers NOVOCURE LTD (NASDAQ), SOTERA HEALTH CO (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), QUIDEL CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), LIVANOVA PLC (NASDAQ), NEOGEN CORP (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), INARI MEDICAL INC (NASDAQ), INMODE LTD (NASDAQ), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), NUVASIVE INC (NASDAQ), AXONICS INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), CAREDX INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), HESKA CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), CUE HEALTH INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), ATRION CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), BIOVENTUS INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), PULMONX CORPORATION (NASDAQ), CERUS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VIEWRAY INC (NASDAQ), AIRSCULPT TECHNOLOGIES INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), SI BONE INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), INOGEN INC (NASDAQ), INTERCURE LTD (NASDAQ), CUTERA INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), NYXOAH SA (NASDAQ), NANO-X IMAGING LTD (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), 908 DEVICES INC (NASDAQ), IRADIMED CORP (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), DERMTECH INC (NASDAQ), LUMIRADX LTD (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), ACCURAY INCORPORATED (NASDAQ), AXOGEN INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ZYNEX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), NEUROPACE INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), EARGO INC (NASDAQ), QUOTIENT LTD (NASDAQ), PROFOUND MED CORP (NASDAQ), CVRX INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), CORMEDIX INC (NASDAQ), SIENTRA INC (NASDAQ), ONCOCYTE CORP (NASDAQ), TELA BIO INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), PAVMED INC (NASDAQ), MINERVA SURGICAL INC (NASDAQ), LUCID DIAGNOSTICS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ),